Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$956M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$924M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$769M |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$410M |
| 5 |
Kenvue
KVUE
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$411M |
| 2 |
Johnson & Johnson
JNJ
|
+$234M |
| 3 |
Cisco
CSCO
|
+$181M |
| 4 |
iShares Gold Trust
IAU
|
+$143M |
| 5 |
LSI
Life Storage, Inc.
LSI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.03% |
| 2 | Healthcare | 12.31% |
| 3 | Financials | 11.79% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Codexis
CDXS
$151M
| $288K | ﹤0.01% |
152,407
-434,996
| -74% | -$1.02M |
|
|
OKUR
3227
OnKure Therapeutics
OKUR
$154M
| $286K | ﹤0.01% |
3,750
+795
| +27% | +$54.1K |
|
3228
Tenaris
TS
$28.9B
| $285K | ﹤0.01% |
+9,032
| New | +$292K |
|
|
PPTA
3229
Perpetua Resources
PPTA
$2.3B
| $282K | ﹤0.01% |
86,353
| – | – |
|
3230
Security National Financial
SNFCA
$244M
| $279K | ﹤0.01% |
41,213
+1
| +0% | +$7 |
|
3231
Foghorn Therapeutics
FHTX
$266M
| $277K | ﹤0.01% |
55,442
| – | – |
|
3232
Rocky Brands
RCKY
$366M
| $277K | ﹤0.01% |
18,826
| – | – |
|
|
GPGI
3233
GPGI Inc
GPGI
$3.83B
| $276K | ﹤0.01% |
51,606
-42,536
| -45% | -$237K |
|
|
XOMA
3234
DELISTED
Xoma
XOMA
| $276K | ﹤0.01% |
19,560
| – | – |
|
3235
Maui Land & Pineapple Co
MLP
$344M
| $275K | ﹤0.01% |
20,741
| – | – |
|
|
KEEL
3236
Keel Infrastructure Corp
KEEL
$2.4B
| $269K | ﹤0.01% |
+251,629
| New | +$368K |
|
3237
Noodles & Co
NDLS
$111M
| $266K | ﹤0.01% |
13,510
| – | – |
|
|
GORV
3238
DELISTED
Lazydays
GORV
| $264K | ﹤0.01% |
1,158
| – | – |
|
|
VOXX
3239
DELISTED
VOXX International Corporation Class A
VOXX
| $263K | ﹤0.01% |
33,001
-4,293
| -12% | -$38.6K |
|
3240
Pearson
PSO
$10.2B
| $262K | ﹤0.01% |
24,872
+14,064
| +130% | +$151K |
|
3241
Rallybio
RLYB
$84.5M
| $260K | ﹤0.01% |
9,627
| – | – |
|
3242
Nuvectis Pharma
NVCT
$678M
| $257K | ﹤0.01% |
19,920
+1,925
| +11% | +$27.9K |
|
3243
Protalix BioTherapeutics
PLX
$191M
| $255K | ﹤0.01% |
153,561
+25,143
| +20% | +$45.1K |
|
3244
Elbit Systems
ESLT
$37.9B
| $252K | ﹤0.01% |
+1,275
| New | +$261K |
|
3245
KORU Medical Systems
KRMD
$189M
| $250K | ﹤0.01% |
92,728
| – | – |
|
3246
Pioneer Bancorp
PBFS
$432M
| $250K | ﹤0.01% |
29,251
| – | – |
|
|
OPTN
3247
DELISTED
OptiNose
OPTN
| $249K | ﹤0.01% |
13,521
| – | – |
|
3248
KVH Industries
KVHI
$181M
| $246K | ﹤0.01% |
48,261
| – | – |
|
3249
Citius Pharmaceuticals
CTXR
$15.6M
| $244K | ﹤0.01% |
14,280
| – | – |
|
3250
Viant Technology
DSP
$236M
| $244K | ﹤0.01% |
43,602
| – | – |
|
Similar funds
Charles Schwab's Q3 2023 Portfolio in Review
As of Q3 2023, Charles Schwab held 3,713 positions worth $349B, down 0.3% from $350B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $12.6B of net new capital in Q3 2023, opening 104 new positions and adding to 2,394 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $234M trimmed.
- Charles Schwab's largest Q3 2023 buy was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
- Charles Schwab added most to iShares Core US Aggregate Bond ETF in Q3 2023, an estimated $956M increase.
- Charles Schwab's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $234M.
- Charles Schwab fully exited iShares 0-5 Year TIPS Bond ETF in Q3 2023, selling an estimated $411M.
- Charles Schwab's ten largest holdings make up 18% of its $349B portfolio in Q3 2023.
- Charles Schwab opened 104 new positions and closed 137 in Q3 2023.
- Charles Schwab's portfolio value fell 0.3% quarter-over-quarter to $349B.
Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.